Literature DB >> 26282955

Evaluation of genotoxicity using automated detection of γH2AX in metabolically competent HepaRG cells.

Nicolas Quesnot1, Karine Rondel1, Marc Audebert2, Sophie Martinais1, Denise Glaise1, Fabrice Morel1, Pascal Loyer3, Marie-Anne Robin1.   

Abstract

The in situ detection of γH2AX was recently reported to be a promising biomarker of genotoxicity. In addition, the human HepaRG hepatoma cells appear to be relevant for investigating hepatic genotoxicity since they express most of drug metabolizing enzymes and a wild type p53. The aim of this study was to determine whether the automated in situ detection of γH2AX positive HepaRG cells could be relevant for evaluation of genotoxicity after single or long-term repeated in vitro exposure compared to micronucleus assay. Metabolically competent HepaRG cells were treated daily with environmental contaminants and genotoxicity was evaluated after 1, 7 and 14 days. Using these cells, we confirmed the genotoxicity of aflatoxin B1 and benzo(a)pyrene and demonstrated that dimethylbenzanthracene, fipronil and endosulfan previously found genotoxic with comet or micronucleus assays also induced γH2AX phosphorylation. Furthermore, we showed that fluoranthene and bisphenol A induced γH2AX while no effect had been previously reported in HepG2 cells. In addition, induction of γH2AX was observed with some compounds only after 7 days, highlighting the importance of studying long-term effects of low doses of contaminants. Together, our data demonstrate that automated γH2AX detection in metabolically competent HepaRG cells is a suitable high-through put genotoxicity screening assay.
© The Author 2015. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26282955     DOI: 10.1093/mutage/gev059

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  6 in total

1.  DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies.

Authors:  Marie Cuvellier; Frédéric Ezan; Georges Baffet; Sophie Langouët; Sophie Rose; Jennifer Carteret; Arnaud Bruyère; Vincent Legagneux; Fabrice Nesslany
Journal:  Arch Toxicol       Date:  2021-11-11       Impact factor: 5.153

2.  Preparation of a mimetic and degradable poly(ethylene glycol) by a non-eutectic mixture of organocatalysts (NEMO) via a one-pot two-step process.

Authors:  S Moins; P Loyer; J Odent; O Coulembier
Journal:  RSC Adv       Date:  2019-12-04       Impact factor: 4.036

3.  Development and Application of TK6-derived Cells Expressing Human Cytochrome P450s for Genotoxicity Testing.

Authors:  Xilin Li; Si Chen; Xiaoqing Guo; Qiangen Wu; Ji-Eun Seo; Lei Guo; Mugimane G Manjanatha; Tong Zhou; Kristine L Witt; Nan Mei
Journal:  Toxicol Sci       Date:  2020-06-01       Impact factor: 4.849

4.  Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay.

Authors:  Marion Mandon; Sylvie Huet; Estelle Dubreil; Valérie Fessard; Ludovic Le Hégarat
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

5.  Enhanced DNA-repair capacity and resistance to chemically induced carcinogenesis upon deletion of the phosphatase regulator NIPP1.

Authors:  Iris Verbinnen; Shannah Boens; Monica Ferreira; Kathelijne Szekér; Louise Van Wijk; Aleyde Van Eynde; Mathieu Bollen
Journal:  Oncogenesis       Date:  2020-03-02       Impact factor: 7.485

6.  Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver Cells.

Authors:  Lisa Goedtke; Heike Sprenger; Ute Hofmann; Felix F Schmidt; Helen S Hammer; Ulrich M Zanger; Oliver Poetz; Albrecht Seidel; Albert Braeuning; Stefanie Hessel-Pras
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.